EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the Diagnostic Value of Lymphocyte Subsets in Bronchoalveolar Lavage Fluid and Peripheral Blood Across Various Diffuse Interstitial Lung Disease Subtypes

Sonoko Harada, Motoyasu Kato iD, Kazuyuki Nakagome iD, Hitoshi Sasano, Yuki Tanabe iD, Tomohito Takeshige, Yuuki Sandhu iD, Kei Matsuno iD, Shoko Ueda iD, Sumiko Abe, Takayasu Nishimaki, Shun Shinomiya und 6 weitere

Biomolecules · 2025

DOI: 10.3390/biom15010122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Sonoko Harada und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo 113-8421, Japan. Hauptthemen laut MEDLINE: Bronchoalveolar Lavage Fluid, Lung Diseases, Interstitial, Lymphocyte Subsets. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Promotion and Mutual Aid Corporation for Private Schools of Japan to the Atopy (Allergy) Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse interstitial lung diseases (ILD) include conditions with identifiable causes such as chronic eosinophilic pneumonia (CEP), sarcoidosis (SAR), chronic hypersensitivity pneumonitis (CHP), and connective tissue disease-associated interstitial pneumonia (CTD), as well as idiopathic interstitial pneumonia (IIP) of unknown origin. In non-IIP diffuse lung diseases, bronchoalveolar lavage (BAL) fluid appearance is diagnostic. This study examines lymphocyte subsets in BAL fluid and peripheral blood of 56 patients with diffuse ILD, excluding idiopathic pulmonary fibrosis (IPF), who underwent BAL for diagnostic purposes. Patients were classified into CEP, SAR, CHP, CTD, and IIP groups, and clinical data, BAL cell analysis, and peripheral blood mononuclear cell analysis were compared. Eosinophils and type 3 innate lymphocytes (ILC3s) were significantly increased in the BAL fluid of the CEP group. Receiver operating characteristic curve analysis identified eosinophils ≥ 8% in BAL cells and ILC3s ≥ 0.0176% in the BAL lymphocyte fraction as thresholds distinguishing CEP. SAR patients exhibited significantly elevated CD4/CD8 ratios in the BAL fluid, with a ratio of 3.95 or higher and type 1 innate lymphoid cell frequency ≥ 0.254% as differentiation markers. High Th1 cell frequency (≥17.4%) in BAL lymphocytes in IIP, elevated serum KL-6 (≥2081 U/mL) and SP-D (≥261 ng/mL) in CHP, and increased BAL neutrophils (≥2.0%) or a low CD4/CD8 ratio (≤1.2) in CTD serve as distinguishing markers for each ILD. Excluding CEP and SAR, CD4+ T cell frequencies, including Th1, Th17, and Treg cells in peripheral blood, may differentiate IIP, CHP, and CTD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchoalveolar Lavage FluidLung Diseases, InterstitialLymphocyte SubsetsHumansMaleFemaleMiddle AgedAgedEosinophilsBiomarkersAdult

Stichwörter der Autor:innen

chronic eosinophilic pneumoniachronic hypersensitivity pneumonitisconnective tissue disease-associated interstitial pneumoniadiffuse interstitial lung diseasesidiopathic interstitial pneumoniasarcoidosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo 113-8421, Japan.
  • Atopy (Allergy) Research Center, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo 113-8421, Japan.
  • Research Institute for Diseases of Old Ages, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo 113-8421, Japan.
  • Department of Respiratory Medicine, Saitama Medical University, Saitama 350-0451, Japan.
  • Department of Immunology, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo 113-8421, Japan.

ORCID-Profile: Motoyasu Kato, Kazuyuki Nakagome, Yuki Tanabe, Yuuki Sandhu, Kei Matsuno, Shoko Ueda, Jun Ito, Kazuhisa Takahashi, Norihiro Harada

Förderung

  • The Promotion and Mutual Aid Corporation for Private Schools of Japan to the Atopy (Allergy) Research Center

Zitieren

APA

Harada, S., Kato, M., Nakagome, K., Sasano, H., Tanabe, Y., Takeshige, T., Sandhu, Y., Matsuno, K., Ueda, S., Abe, S., Nishimaki, T., Shinomiya, S., Ito, J., Miyake, S., Okumura, K., Nagata, M., Takahashi, K., & Harada, N. (2025). Evaluating the Diagnostic Value of Lymphocyte Subsets in Bronchoalveolar Lavage Fluid and Peripheral Blood Across Various Diffuse Interstitial Lung Disease Subtypes. Biomolecules. https://doi.org/10.3390/biom15010122

Vancouver

Harada S, Kato M, Nakagome K, Sasano H, Tanabe Y, Takeshige T, et al. Evaluating the Diagnostic Value of Lymphocyte Subsets in Bronchoalveolar Lavage Fluid and Peripheral Blood Across Various Diffuse Interstitial Lung Disease Subtypes. Biomolecules. 2025. doi:10.3390/biom15010122

BibTeX
@article{Harada2025,
  author = {Harada, Sonoko and Kato, Motoyasu and Nakagome, Kazuyuki and Sasano, Hitoshi and Tanabe, Yuki and Takeshige, Tomohito and Sandhu, Yuuki and Matsuno, Kei and Ueda, Shoko and Abe, Sumiko and Nishimaki, Takayasu and Shinomiya, Shun and Ito, Jun and Miyake, Sachiko and Okumura, Ko and Nagata, Makoto and Takahashi, Kazuhisa and Harada, Norihiro},
  title = {Evaluating the Diagnostic Value of Lymphocyte Subsets in Bronchoalveolar Lavage Fluid and Peripheral Blood Across Various Diffuse Interstitial Lung Disease Subtypes},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15010122}
}
Kostenlos starten →